Quality of life of metastatic urothelial cancer (mUC) patients treated with enfortumab vedotin (EV) following platinum-containing chemotherapy and a checkpoint inhibitor (CPI): Data from EV-201 cohort 1 Meeting Abstract
| Authors: | McGregor, B. A.; O'Donnell, P. H.; Balar, A.; Petrylak, D. P.; Rosenberg, J. E.; Yu, E.; Quinn, D. I.; Shah, S. N.; Pinelli, J.; Hepp, Z.; Galsky, M. |
| Abstract Title: | Quality of life of metastatic urothelial cancer (mUC) patients treated with enfortumab vedotin (EV) following platinum-containing chemotherapy and a checkpoint inhibitor (CPI): Data from EV-201 cohort 1 |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz249.020 |
| Language: | English |
| ACCESSION: | WOS:000491295502348 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz249.020 |
| Notes: | Meeting Abstract: 921P -- Appears on pages v367-v368 of the abstract book-- Source: Wos |
